Publication | Closed Access
Randomized controlled trial of an oral CGRP receptor antagonist, MK-0974, in acute treatment of migraine
461
Citations
7
References
2007
Year
The novel, orally administered calcitonin gene-related peptide (CGRP) receptor antagonist, MK-0974, was effective and generally well tolerated for the acute treatment of migraine.
| Year | Citations | |
|---|---|---|
Page 1
Page 1